Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.61 |
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.61 |
| ▸ | CHRM3 known ✓ | P20309 | 2/20 | 0.61 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.61 |
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 0.61 |
| ▸ | SLC6A3 known ✓ | Q01959 | 2/20 | 0.61 |
| ▸ | BDKRB2 known ✓ | P30411 | 1/20 | 0.60 |
| ▸ | TP53 | P04637 | 5/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.61 |
| ▸ | MEN1 | O00255 | 5/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.61 |
| ▸ | TSHR | P16473 | 4/20 | 0.61 |
| ▸ | HTT | P42858 | 4/20 | 0.61 |
| ▸ | APAF1 | O14727 | 3/20 | 0.61 |
| ▸ | USP2 | O75604 | 3/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | RAD52 | P43351 | 3/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL5156049 | 0.86 | SMN1; SMN2 (0.70) | TP53SMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL9324544 | 0.84 | SMN1; SMN2 (0.70) | TP53SMN1; SMN2MEN1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL10939133 | 0.81 | MEN1 (0.63) | TP53SMN1; SMN2MEN1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL11659854 | 0.79 | MEN1 (0.59) | TP53SMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL19916799 | 0.79 | KMT2A (0.78) | TP53SMN1; SMN2MEN1KMT2AALDH1A1 | |
| Hydrochloric Acid SCHEMBL9656431 | 0.78 | ALDH1A1 (0.48) | TP53SMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL18123234 | 0.77 | MEN1 (0.60) | TP53SMN1; SMN2MEN1KMT2AALDH1A1 | |
| Bephenium SCHEMBL9118297 | 0.77 | HTT (0.58) | TP53SMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL16353091 | 0.77 | SMN1; SMN2 (0.74) | TP53SMN1; SMN2MEN1KMT2AALDH1A1 | |
| Benzethonium SCHEMBL27797280 | 0.76 | SMN1; SMN2 (1.00) | TP53SMN1; SMN2MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0747092-B1 | Matrix for iontophoresis | HISAMITSU PHARMACEUTICAL CO (JP) | 2003-12-03 | — | — | EP | disclosed |
| EP-0748636-B1 | Interface for iontophoresis | HISAMITSU PHARMACEUTICAL CO (JP) | 2003-08-27 | — | — | EP | disclosed |
| EP-0950407-B1 | The use of a GP IIb/IIIa antagonist for the manufacture of a medicament suitable for transdermal application by iontophoresis | HISAMITSU PHARMACEUTICAL CO (JP) | 2002-09-04 | — | — | EP | disclosed |
| EP-0732122-B1 | Stabilized interface for iontophoresis | HISAMITSU PHARMACEUTICAL CO (JP) | 2001-09-19 | — | — | EP | disclosed |
| US-6248349-B1 | LIQUID HUMECTANT | HISAMITSU PHARMACEUTICAL CO., INC. (JP) | 2001-06-19 | — | — | US | disclosed |
| EP-0950407-A1 | Method for transdermal administration of GP IIb/IIIa antagonist | Takeda Chemical Industries, Ltd. (JP) | 1999-10-20 | — | — | EP | disclosed |
| US-5837281-A | Stabilized interface for iontophoresis | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-11-17 | — | — | US | disclosed |
| EP-0748636-A2 | Interface for iontophoresis | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-12-18 | — | — | EP | disclosed |
| EP-0747092-A2 | Dissolution liquid for drug in iontophoresis | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-12-11 | — | — | EP | disclosed |
| EP-0732122-A1 | Stabilized interface for iontophoresis | Takeda Chemical Industries, Ltd. (JP) | 1996-09-18 | — | — | EP | disclosed |